Blog

Cancer Institute NSW is shortlisted for the prestigious 2024 Festival of Media Asia Pacific Awards

Photo from Tracey O'Brien/LinkedIn

Apr 29, 2024, 15:45

Cancer Institute NSW is shortlisted for the prestigious 2024 Festival of Media Asia Pacific Awards

Tracey O’Brien shared a post by Cancer Institute NSW, on LinkedIn:

“Congratulations to the all the Cancer Institute NSW team that worked hard on this important public health behaviour change campaign. Being nominated for a prestigious industry award is great but even better is the evaluation research which demonstrates great impact in helping people understand the harms of vaping and providing motivation to quit.”

Quoting Cancer Institute NSW‘s post:

“We are honoured to be shortlisted for the prestigious 2024 Festival of Media Asia Pacific Awards – Best Response Campaign and Best Use of Data for the 2022-23 Anti-Vaping Campaign, ‘Do you know what you’re vaping?

Congratulations to Social Marketing and Campaigns Team and everyone involved in the campaign’s success. We’re committed to sharing up-to-date information on the growing evidence around vaping and supporting people to quit and be healthy, and our work in NSW is having an impact around the world.

Award winners will be announced on 18 April.”

Cancer Institute NSW

Read further.
Source: Tracey O’Brien/LinkedIn and Cancer Institute NSW/LinkedIn

Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group. In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.